Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,591,762
+$9,984,996 QoQ
Shares Held
35,510
+0.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#593
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IHT Wealth Management, LLC holds $107,151,979 across 12 Drug Manufacturers - General names. LLY ranks #1 (39.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
35,510 | $42,591,762 | |
| 2 | ABBV |
AbbVie Inc.
|
78,550 | $19,766,322 | |
| 3 | JNJ |
Johnson & Johnson
|
62,778 | $15,943,728 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,265 | $7,358,552 | |
| 5 | AMGN |
Amgen Inc
|
13,902 | $5,034,192 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
72,038 | $4,150,829 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,870 | $4,026,455 | |
| 8 | PFE |
Pfizer Inc
|
148,377 | $3,572,917 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,591,762 | 35,510 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $32,606,766 | 35,451 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,477,907 | 30,221 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,176,418 | 31,686 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,115,540 | 30,936 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $25,006,077 | 30,277 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,945,408 | 18,064 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,989,671 | 19,177 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,038,604 | 46,432 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $45,335,619 | 58,275 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,206,328 | 58,681 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,871,682 | 59,337 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,491,941 | 60,753 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $6,833,714 | 19,899 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,415,004 | 17,535 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,479,489 | 16,946 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $4,269,460 | 13,168 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,617,712 | 12,633 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,363,807 | 12,178 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,783,921 | 12,049 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,472,867 | 15,131 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,720,659 | 14,563 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,102,902 | 12,455 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,821,090 | 12,303 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,887,413 | 11,496 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,676,015 | 12,082 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||